Navigation Links
Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus
Date:2/6/2012

ANN ARBOR, Mich., Feb. 6, 2012 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today executive management transitions and Board of Director appointments to strengthen and expand the Company's leadership, as follows:

  • Jeff Riley, a member of the Adeona Board of Directors since March 2010 and Chairman of the Board since November 2011, was appointed as the Company's President and Chief Executive Officer.
  • Scott L. Tarriff and Nelson K. Stacks were appointed independent members of the Company's Board of Directors.

James S. Kuo will continue to serve on the Company's Board of Directors, having resigned from his day-to-day management positions to pursue other opportunities. Mr. Riley has stepped down from Adeona's Audit and Nominations Committees; independent director, Jeffrey Kraws, was elected to the Nominations Committee and Mr. Stacks was elected to the Audit Committee.

"As we align ourselves with our new focus on the emerging field of synthetic biologics, these management transitions and board appointments position Adeona to benefit from the expertise of each of these experienced life science leaders. The Board of Directors welcomes Jeff to the executive management team as he assumes the responsibilities of CEO. Jeff's considerable management and financial experience during his career will help shape the vision and skills needed to lead Adeona to future success," said Jeffrey Kraws, on behalf of the Board of Directors. "We also thank Jim for his service to Adeona as he transitions out of his management role, and appreciate the continuity he will bring to the Company as a member of the Board."

Mr. Riley has more than 20 years of experience in the biotechnology and pha
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
2. Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
3. Adeona Reports Third Quarter 2011 Financial Results
4. Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
5. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
6. Adeona Appoints Jeff Lucero Riley as Independent Chairman
7. Adeonas Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease is Hot Topic at 2011 California ALS Research Summit
8. Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
9. Adeona Appoints George A. Eby to Scientific Advisory Board
10. Adeona Reports Second Quarter 2011 Financial Results
11. Adeona to Host Second Quarter 2011 Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Using publicly released 2015 rate filings in ... five common specialty drugs. Specialty drugs have been ... costs and shortage of generic alternatives. They treat ... and are used for a broad variety of ... HealthPocket found that among 2015 Obamacare ...
(Date:8/26/2014)... ALISO VIEJO, Calif. , Aug. 26, 2014 ... ) today announced the enrollment of the first ... the efficacy, safety and tolerability of AVP-786 for ... AVP-786 is a novel investigational drug consisting of ... dose quinidine. "There are millions of ...
(Date:8/26/2014)... Calif. , Aug. 26, 2014  Based on its ... Sullivan recognizes Volpara Solutions with the 2014 North American Frost ... an innovative range of volumetric breast imaging solutions for the ... the company has steadily introduced several new solutions and has ... States , Europe , ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5
... 12, 2011 Breast Imaging facilities looking ... benefit from the exceptional image quality of the Aspire™ ... Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the ... of potential abnormalities that not only assists in more ...
... 2011 Henry Schein, Inc., (NASDAQ: ... services to office-based practitioners, announced today that Steven ... will present at the Morgan Stanley Global Healthcare Conference.  The ... City.   Henry Schein,s presentation is scheduled to ...
Cached Medicine Technology:Fujifilm's Aspire HD Receives FDA Clearance 2Fujifilm's Aspire HD Receives FDA Clearance 3Henry Schein to Present at the Morgan Stanley Global Healthcare Conference 2
(Date:8/27/2014)... Neil Haley, the Total Tutor host of the Simply ... about the importance of capacity to grow a business. , ... and is now a 5 Star Ambassador, Vi Millionaire, and ... titled "The Playful and Powerful Warrior Within You!" and holds ... out for over 1000 days straight. He is also ...
(Date:8/27/2014)... 27, 2014 Overcoming a turbulent past which ... his niche. The Women’s Radio Network, WRNW1, has recently signed ... support and dedication to the WRNW1 family. KC states, “it ... such a positive atmosphere.” After KC Armstrong publicly announced his ... the Howard Stern show, “Howard 100 News,” have decided to ...
(Date:8/27/2014)... A recently published study ... time in correcting coagulopathy to prevent permanent injury or ... anticoagulants and examines medical conditions alleged to be caused ... anticoagulants have been approved by the FDA to reduce ... also known to affect the consistency of the anticoagulation ...
(Date:8/27/2014)... August 27, 2014 The use of ... of life and may eliminate the need for blood ... a recent AllMed webinar, Dr. Zanhua Yi, board certified ... to determining medical necessity of erythropoiesis-stimulating agents (ESAs) in ... , The U.S. Food and Drug Administration (FDA) has ...
(Date:8/27/2014)... Frederick, MD (PRWEB) August 27, 2014 ... and family-friendly practices as the “Most Creative Workplace” ... Frederick County Best Places to Work Awards. , ... the annual event is a joint partnership between ... Department of Economic Development, Frederick County Business Development ...
Breaking Medicine News(10 mins):Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 2Health News:Vi Millioniare GJ Reynolds Discusses The Importance of Capacity to Grow a Business on the Simply G Radio Show, a Division of the Simply G Media Network 3Health News:The Women's Radio Network, WRNW1, Signs KC Armstrong to a Multi-Million Dollar Contract 2Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:iHire Named Most Creative Workplace in Frederick, MD 2
... tall extremes may put added pressure on joints, study ... Common genetic variants associated with osteoarthritis may also play ... a U.S.-European study. , The findings, which included an ... are exciting for a number of reasons, said ...
... Childrens Hospital has been named the national lead ... the German-manufactured pediatric heart pump called Berlin Heart ... Fraser, Jr., MD, chief of pediatric and congenital ... E. DeBakey Department of Surgery at Baylor College ...
... transplanted because of the generosity of,donors and their families, ... Perkiomenville, 2007 was a year that brought the greatest ... for a multi-organ,transplant, her parents Shane and Jill watched ... a miracle., That wish was answered just three ...
... today that the United States Food and,Drug Administration ... first LDL cholesterol lowering medication also indicated for,improving ... mellitus (DM) in,combination with metformin, sulfonylureas, or insulin, ... with other anti-diabetic agents., The ADA estimates ...
... Joined by New York City Mayor,Michael Bloomberg, Lance ... today discussed Lance,s request to the Surgeons General,Collective ... "This year alone, 1.4 million Americans are ... likely lose their lives to the disease," said,Lance ...
... the San Diego Supercomputer Center and other parts of ... in Parkinsons Disease, fusion energy and climate change - ... Energy (DOE) as part of its 2008 Innovative and ... , In total, the DOEs Office of Science awarded ...
Cached Medicine News:Health News:Genes Linked to Height Also Tied to Osteoarthritis Risk 2Health News:National study will look at German-made heart pump for children needing heart transplants 2Health News:National study will look at German-made heart pump for children needing heart transplants 3Health News:Gift of Life Celebrates Saving Lives and Setting Records in 2007 2Health News:Gift of Life Celebrates Saving Lives and Setting Records in 2007 3Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:DOE awards supercomputing time to UCSD, SDSC researchers 2Health News:DOE awards supercomputing time to UCSD, SDSC researchers 3
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full menu ... thyroid, reproductive, cardiac, and anemia assays. ,The ... bar-coded primary tube sampling, auto dilution, auto ...
... Tosoh, innovators of automated random access immunoassay testing, ... builds on the proven reliability of Tosohs original ... rapid result processing, and continuous process operation., Test ... T4 FT3 FT4 T-Uptake ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... Vitros ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The Vitros ECi can simultaneously process ...
Medicine Products: